Ensysce Biosciences (ENSC) Share-based Compensation (2020 - 2025)
Ensysce Biosciences (ENSC) recorded Share-based Compensation of -$50,267 in Q3 2025, compared with $20,818 a year earlier.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Share-based Compensation (2020 - 2025) Analysis & Trends
On a TTM basis, Ensysce Biosciences' Share-based Compensation came in at $182,896 as of Sep 30, 2025, down 74.2% year-over-year; for FY2024, it was $110,723, down 87.4% from FY2023.
- Annual Share-based Compensation has a four-year compound annual growth rate of -11.3% (FY2020 to FY2024).
- Across earlier years, Share-based Compensation came in at $879,160 in FY2023 (-49.5%), $1.74 million in FY2022, $121,764 in FY2021 (-31.9%) and $178,679 in FY2020.
- The Q3 2025 figure is the lowest quarterly Share-based Compensation in data going back to Q3 2020.
- On a year-over-year basis, Share-based Compensation rose in 1 of the last six quarters, with growth averaging 42.9%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 603.5% in Q2 2025, against a decline of 100.0% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $186,763 (Q2 2025), $16,251 (Q1 2025) and $30,149 (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Ensysce Biosciences | 1.02 Mn | -10.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -50,267.00 |
| Jun 30, 2025 | 186,763.00 |
| Mar 31, 2025 | 16,251.00 |
| Dec 31, 2024 | 30,149.00 |
| Sep 30, 2024 | 20,818.00 |
| Jun 30, 2024 | 26,549.00 |
| Mar 31, 2024 | 33,207.00 |
| Dec 31, 2023 | 628,936.00 |
| Sep 30, 2023 | 55,674.00 |
| Jun 30, 2023 | 77,417.00 |
| Mar 31, 2023 | 117,133.00 |
| Dec 31, 2022 | 3.00 |
| Sep 30, 2022 | -1.00 |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 16,738.00 |
| Sep 30, 2021 | 24,833.00 |
| Jun 30, 2021 | 36,373.00 |
| Mar 31, 2021 | 43,820.00 |
| Dec 31, 2020 | 58,618.00 |
| Sep 30, 2020 | 51,510.00 |
API Access
Ensysce Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();